XNASCLVR
Market cap0kUSD
Dec 20, Last price
0.00USD
1D
19,900.00%
1Q
-33.33%
IPO
-100.00%
Name
Clever Leaves Holdings Inc
Chart & Performance
P/E
—
P/S
0.00
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
0.00%
Revenues
17m
-2.15%
Net income
-18m
L-72.92%
CFO
-12m
L-60.41%
Earnings
Mar 31, 2025
Profile
Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 17,417 -2.15% | 17,800 15.78% | 15,374 26.88% | |||
Cost of revenue | 32,030 | 44,901 | 52,305 | |||
Unusual Expense (Income) | ||||||
NOPBT | (14,613) | (27,101) | (36,931) | |||
NOPBT Margin | ||||||
Operating Taxes | 68 | (6,354) | 950 | |||
Tax Rate | ||||||
NOPAT | (14,681) | (20,747) | (37,881) | |||
Net income | (17,899) -72.92% | (66,101) 44.86% | (45,631) 10.18% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 1,339 | 27,686 | 1,420 | |||
BB yield | -40.78% | -234.89% | -1.78% | |||
| Debt | ||||||
Debt current | 1,270 | 1,704 | 17,508 | |||
Long-term debt | 2,072 | 4,478 | 7,587 | |||
Deferred revenue | 1,548 | |||||
Other long-term liabilities | 12 | 112 | 360 | |||
Net debt | (3,489) | (11,946) | (13,589) | |||
| Cash flow | ||||||
Cash from operating activities | (11,508) | (29,066) | (36,233) | |||
CAPEX | (31) | (1,306) | (7,280) | |||
Cash from investing activities | 4,694 | 1,192 | (7,280) | |||
Cash from financing activities | 656 | 3,289 | 1,834 | |||
FCF | (5,876) | (1,294) | (45,974) | |||
| Balance | ||||||
Cash | 6,831 | 12,449 | 37,226 | |||
Long term investments | 5,679 | 1,458 | ||||
Excess cash | 5,960 | 17,238 | 37,915 | |||
Stockholders' equity | (198,804) | (177,542) | (114,740) | |||
Invested Capital | 225,892 | 221,918 | 214,513 | |||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 1,568 | 1,280 | 856 | |||
Price | 2.09 -77.26% | 9.21 -90.10% | 93.00 -65.17% | |||
Market cap | 3,283 -72.14% | 11,787 -85.20% | 79,639 -64.04% | |||
EV | (206) | (159) | 66,050 | |||
EBITDA | (11,765) | (23,429) | (33,423) | |||
EV/EBITDA | 0.02 | 0.01 | ||||
Interest | 46 | 2,702 | 6,818 | |||
Interest/NOPBT | ||||||